Replacement of the Native Mitral Valve Using the ReValve System

NCT07601269 · Status: RECRUITING · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-05-22

No results posted yet for this study

Summary

This study is to collect preliminary chronic information on performance and safety of the ReValve System.

Conditions

  • Mitral Valve Replacement

Interventions

DEVICE

ReValve System

Mitral Valve Replacement Device

Sponsors & Collaborators

  • ReValve Solutions Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-26
Primary Completion
2028-04-30
Completion
2028-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07601269 on ClinicalTrials.gov